NCT03984708View on ClinicalTrials.gov

New Therapeutic Strategy in ALS Based on Metabolic Status and Associated Metabolic Pathways.

NAActive, not recruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 27, 2020

Primary Completion Date

January 10, 2023

Study Completion Date

January 31, 2024

Conditions
Amyotrophic Lateral Sclerosis
Interventions
OTHER

Samples

Blood sample, skin biopsy

OTHER

Indirect calorimetry

Measurement of energy expenditure by indirect calorimetry

OTHER

Electrical bioimpedance

Measurement of electrical bioimpedance

Trial Locations (2)

37044

Neurology Department, University Hospitla, Tours, Tours

87042

Neurology Department, University Hospital, Limoges, Limoges

All Listed Sponsors
lead

University Hospital, Tours

OTHER